Mesenteric Paraganglioma: An Unusual Suspect To Consider

Andreia Martins Fernandes1, Raquel Prata Saraiva2, Leandro Augusto Silva1

  • 1Endocrinology, Portuguese Institute of Oncology of Coimbra, Coimbra, PRT.

Cureus
|November 7, 2024
PubMed

Insights

Mesenteric paragangliomas (PGLs) are rare tumors. This case highlights the diagnostic challenges and emphasizes surgical management and long-term follow-up for these rare mesenteric masses.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Mesenteric paragangliomas (PGLs) are exceptionally rare neuroendocrine tumors.
  • They often present asymptomatically or with non-specific symptoms like abdominal pain.

Observation:

  • A 48-year-old male presented with severe abdominal pain, later found to have a mesenteric mass.
  • Preoperative diagnostics, including biopsy, could not definitively distinguish between an epithelial neuroendocrine tumor and a paraganglioma.

Findings:

  • Histopathological examination of the resected surgical specimen confirmed the diagnosis of a paraganglioma.
  • The patient remains asymptomatic with no signs of metastasis after two years of follow-up.

Implications:

  • Mesenteric paragangliomas require consideration in the differential diagnosis of mesenteric masses.
  • Surgical resection is the primary treatment, necessitating lifelong monitoring for potential recurrence or metastasis.